2021 (109 POSTS)

Gentry R, Greene T, Chappell G, Lea I, Borghoff S, Yang C, Rathman J, Ribeiro JV, Hobocienski B, Mostrag A, Rodricks J, Clewell H. 2021. Integration of evidence to evaluate the potential for neurobehavioral effects following exposure to USFDA-approved food colors. Food Chem Toxicol 151:112097. doi: 10.1016/j.fct.2021.112097. Epub 2021 Mar 4. PMID: 33677041.

View Abstract

Lea IA, Chappell GA, Wikoff DS. 2021. Overall lack of genotoxic activity among five common low- and no-calorie sweeteners: A contemporary review of the collective evidence. Mutat Res Genet Toxicol Environ Mutagen 868–869:503389. doi: 10.1016/j.mrgentox.2021.503389. PMID: 34454695.

View Abstract

Heintz MM, Doepker CL, Wikoff DS, Hawks SE. 2021. Assessing the food safety risk of ochratoxin A in coffee: A toxicology-based approach to food safety planning. J Food Sci 86(11):4799-4810; doi: 10.1111/1750-3841.15938.

View Abstract

Feuerstadt P, Boules M, Stong L, Dahdal DN, Sacks NC, Lang K, Nelson WW. 2021. Clinical complications in patients with primary and recurrent Clostridioides difficile infection: A real-world data analysis. SAGE Open Med 9:2050312120986733.

View Abstract

Hackshaw A, Cohen SS, Reichert H, Kansal AR, Chung KC, Ofman JJ. 2021. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. Brit J Cancer, open access.

View Abstract

Barnett LMA, Kramer NE, Buerger AN, Love DH, Bisesi JH, Cummings BS. 2021. Transcriptomic analysis of the differential nephrotoxicity of diverse brominated flame retardants in rat and human renal cells. Int J Mol Sci 22(18):10044.

View Abstract

Snell Taylor SJ, Nielson CM, Breskin A, Saul B, Yu Y, Alam N, … Kelsh M, et al. 2021. Effectiveness and safety of romiplostim among patients with newly diagnosed, persistent and chronic immune thrombocytopenia in European clinical practice. Adv Ther 38(5):2673–2688.

View Abstract

McGrath LJ, Nielson C, Saul B, Breskin A, Yu Y, Nicolaisen SK, … Kelsh M, et al. 2021. Lessons learned using real-world data to emulate randomized trials: A case study of treatment effectiveness for newly diagnosed immune thrombocytopenia. Clin Pharmacol Ther 110(6):1570–1578. doi: 10.1002/cpt.2399.

View Abstract

Catlin NR, Cappon GD, Engel S, Rohde CM, Nowland WS, Buitrago S, et al. 2021. Maternal Immunization with Group B streptococcus 6-valent polysaccharide conjugate vaccine supported by lack of toxicity in rat and rabbit fertility and developmental toxicity studies. Birth Defects Res 113(19):1343–1356, DOI: 10.1002/bdr2.1953, article online.

View Abstract

Haddadin Z, Rankin DA, Lipworth L, Suh M, McHenry R, Blozinski A, Salib George S, Fernandez KN, Varjabedian R, Spieker AJ, Shepard DS, Halasa NB. 2021. Respiratory virus surveillance in infants across different clinical settings. J Pediat 234(July):p164-p171, doi: 10.1016/j.jpeds.2021.03.036.

View Abstract

Vágó EK, Nicholson G, Horváth-Puhó E. Hooda N, Fryzek JP, Su J. 2021. Healthcare resource utilization among patients with cold agglutinin disease in Denmark. Curr Med Res Opin 37(10):1829-1835; doi: 10.1080/03007995.2021.1960494.

View Abstract

Huard K, Smith A, Cappon G, Dow R, Edmonds D, El-Kattan A, et al. 2020. Optimizing the benefit/risk of acetyl-CoA carboxylase (ACC) inhibitors through liver targeting. J Med Chem 63(19):10879–10896; doi: 10.1021/acs.jmedchem.0c00640.

View Abstract

Sacks NC, Healey BE, Cyr PL, Slocomb T, James E, Beggs AH, Graham RJ. 2021. Costs and health resource use in patients with X-linked myotubular myopathy: insights from U.S. commercial claims. J Manag Care Spec Pharm 27(8):1019–1026; doi: 10.18553/jmcp.2021.20501.

View Abstract

Bowman CJ, Bouressam M, Campion SN, Cappon GD, Catlin NR, Cutler MW, et al. 2021 Lack of effects on female rat fertility and pre/postnatal development with BNT162b2, a mRNA-based COVID-19 vaccine. Reprod Toxicol 103(Aug):28–35; doi: 10.1016/j.reprotox.2021.05.007.

View Abstract

Doepker CD, Heintz MM, van de Ligt JLG, Wikoff DS. 2021. Review of potential risks associated with supplementary dietary exposure to nitrate-containing compounds in swine — A paradox in light of emerging benefits. Trans Anim Sci 5(4):txab203.

View Abstract

van de Ligt JLG, Saddoris-Clemens KL, Norton SA, Davis MD, Doepker CL. 2021. Impact of calcium nitrate supplementation on the oxygen-carrying capacity of lactating sows and their offspring. Trans Anim Sci 5(4):txab217; doi: 10.1093/tas/txab217.

View Abstract

East A, Isaacs K, Vallero D. Application of the Residential Population Generator (RPGen) in prediction of exposure outcomes for owners and renters from consumer products using the Combined Human Exposure Model (CHEM). Symposium presented at International Society of Exposure Science Annual Meeting, Virtual, September 2021; doi: 10.23645/epacomptox.16632319.

View Abstract

East A, Brady S, Isaacs K, Vallero D. The role of the Product Use Scheduler (PUS) in determining product use categories (PUCs) for owners and renters in the Combined Human Exposure Model (CHEM). Symposium presented at International Society of Exposure Science Annual Meeting, virtual, September 2021; doi: 10.23645/epacomptox.16632271.

View Abstract

Fisher H, East A, Vallero D. Estimating longitudinal aggregate exposure — The third module of CHEM: Source to dose. Symposium presented at International Society of Exposure Science Annual Meeting, virtual conference, September 2021; doi: 10.23645/epacomptox.16630675.

View Abstract

East A, Dawson D, Glen G, Isaacs K, Dionisio K, Price PS, et al. 2021. The Residential Population Generator (RPGen): Parameterization of residential, demographic, and physiological data to model intraindividual exposure, dose, and risk. Toxics 9(11):303; doi: 10.3390/toxics9110303.

View Abstract